N-Terminal Pro-Brain Natriuretic Peptide on Admission Has Prognostic Value Across the Whole Spectrum of Acute Coronary Syndromes
Marcello Galvani(Ospedale Maggiore), C Vecchio(Ente Ospedaliero Ospedali Galliera), Marco Tubaro(Ospedale Maggiore), Diego Ardissino(University of Leeds), Pier Mannuccio Mannucci(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Filippo Ottani(Ospedale Maggiore), Aldo P. Maggioni(Health Care Foundation), N Mininni(Ospedale Maggiore), Arialdo Vernocchi(Ospedale Maggiore), Gian Franco Gensini(Tecnologie Avanzate (Italy)), Luigi Oltrona(Ospedale Maggiore), Maria D. Prando(Ospedale Maggiore)
Cited by 252
Related Papers
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2007|6.7k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012
|European Journal of Heart Failure|2012|2.6k
Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both
|New England Journal of Medicine|2003|2.5k
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
|New England Journal of Medicine|2015|2.3k